Award
Delivery Order #SPE2D326F171Y
Pfizer Delivery Order for Injectable Tranexamic Acid
Buyer
Defense Logistics Agency
Award Amount
$134.76
Ceiling
$134.76
Awarded
June 05, 2026
Period of Performance
Jun 05, 2026 – Jun 08, 2026
Identifier
SPE2D326F171Y
NAICS
325412
This is a short-term delivery order under a broader Department of Defense indefinite delivery vehicle held by Pfizer Inc., a pharmaceutical company. It covers CYKLOKAPRON (tranexamic acid), an injectable medicine supplied in 1,000 mg/10 mL vials, for delivery in New York. The order supports access to an essential medication used to help control bleeding and contributes to military medical supply readiness. It was issued under Pfizer’s existing supply vehicle; the data provided does not identify whether this individual order was competed or sole-source, nor does it provide a justification. The parent vehicle is a long-term arrangement for pharmaceutical manufacturing and distribution and is identified as competitively awarded. The order’s performance period is brief and falls within the parent vehicle’s extended term. No acquisition program, subcontractors, prior related task orders, or original solicitation details are provided.
Description
4572042654!CYKLOKAPRON 1,000 MG/10 ML VL 10ML